✦ LIBER ✦

Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation

✍ Scribed by Jenke, A; Freiberg-Richter, J; Johne, C; Knoth, H; Schleyer, E; Ehninger, G; Bornhäuser, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Establishing a Target Exposure for Once-

✍ Russell, James A.; Kangarloo, Shahbal B.; Williamson, Tyler; Chaudhry, M. Ahsan; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Maximally Tolerated Busulfan Systemic Ex

✍ Janelle B. Perkins; Jongphil Kim; Claudio Anasetti; Hugo F. Fernandez; Lia E. Pe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 304 KB

Once daily intravenous busulfan as part

✍ M. Mates; H. Michalska; W. Hasegawa; T. Kiss; A. Daly; D. Loach; H. Messner; J. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety Profile of Pharmacokinetically Ta

✍ J. Perkins; M. Alsina; E. Ayala; K. Fancher; H. Fernandez; M. Kharfan-Dabaja; L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Once-daily intravenous busulfan given wi

✍ J.A Russell; H.T Tran; D Quinlan; A Chaudhry; P Duggan; C Brown; D Stewart; J.D 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Randomized Comparison of Four-Times-Dail

✍ Seong-Gil Ryu; Je-Hwan Lee; Seong-Jun Choi; Jung-Hee Lee; Young-Shin Lee; Miee S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 312 KB